Aktienanalyse zu Huron Consulting Group Inc (HURN)HURNHuron Consulting Group Inc

Huron Consulting Group Inc. is a global professional service. The Company operates in three segments: Healthcare, Education, and Commercial. The Healthcare segment serves acute care providers, including national and regional health systems; academic health systems; community health systems; the federal health system; and public, children’s and critical access hospitals, and non-acute care providers, including physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment serves public and private colleges and universities, research institutes, not-for-profit organizations and other education-related organizations. The Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Its products include TriZetto’s Facets, QNXT, and HealthEdge solutions. It operates in the Industrials sector (SERVICES-MANAGEMENT CONSULTING SERVICES industry).

Huron Consulting Group Inc is a good buy right now due to its strong recent performance and positive outlook. The current price is $195.69, and the stock has shown a remarkable 11.91% increase over the last 5 days and a 23.87% increase over the last 20 days. Additionally, the forward P/E ratio is 14.51, indicating potential undervaluation compared to its growth prospects. However, the main risk is the significant insider selling, which has increased by 196.55% over the last month, suggesting potential concerns among insiders about the stock's future performance.

4 analysts cover HURN: 2 rate it Buy, 2 Hold and 0 Sell. The average price target is 211.00.